• Diversified portfolio for sustainable growth offers multiple revenue options
• Entry into legalized cannabis market continues with acquisition of multiple cannabis companies
• Ancillary cannabis-related businesses poised to reap healthy portion of multi-billion-dollar industry

SinglePoint, Inc. (OTC: SING) has evolved from a full-service provider of mobile technology to a publicly traded holding company focused on diversifying into horizontal markets that offer multiple revenue streams for investors. Key to this approach is SinglePoint’s strategic expansion into the burgeoning legal marijuana industry, which includes the acquisition of several important cannabis-related brands.

Projected growth estimates for the legal marijuana industry continue to brighten the mood of investors, with ArcView Market Research noting the North American cannabis market alone is expected to reach $22 billion by 2021 (http://dtn.fm/JDHs7). Globally, the market is estimated to reach over $55 billion by 2025. SinglePoint is positioning itself to take full advantage of a variety of business opportunities this booming market presents for those willing to seek revenue in supportive or horizontal ventures.

SinglePoint’s most recent announcement that it intends to acquire 51 percent of a Colorado-based company approaching $1 million in annual revenue drives home the success of its revenue-by-acquisition model (http://dtn.fm/3AGwP).

In March 2017, SinglePoint’s investment in Convectium, a California-based provider of equipment, packaging and branding solutions for the cannabis industry, propelled the company’s business reach. Two months later, SinglePoint acquired Discount Indoor Garden Supply (DIGS), which supplies soil, supplies hydroponics and consulting services to legal cannabis growers in California. Each of these successful acquisitions is factored into SinglePoint’s strategic plan to create additional revenue streams while identifying undervalued companies to consider as potential targets.

Meanwhile, SinglePoint’s SingleSeed subsidiary (www.SingleSeed.com) continues to offer various services to marijuana enterprises, including payment processing and text messaging marketing solutions. SingleSeed Payments exists to educate and inform customers and shopkeepers of the changing key issues in the retail and medicinal cannabis market while helping to legitimize the industry. By staying flexible and responsive to these changes, SingleSeed provides its customers with a unique experience backed by an ethical and responsible approach to challenges facing the cannabis industry.

SinglePoint’s proactive approach to seeking out new business ventures has increased the company’s revenue 378-fold in Q2, as compared with the first quarter of 2017. This ability to specialize through the acquisition of small to mid-sized companies, with an emphasis on new technologies, provides investors with the opportunity to reap rewards across a wide range of assets.

For more information, visit the company’s website at www.SinglePoint.com

Let us hear your thoughts: SinglePoint, Inc. Message Board

• Strategic holdings in telemedicine, remote diagnostics, healthcare services, medical device development and patient services
• Feds have endorsed telehealth services, signaling growth opportunities for Medical Innovation Holdings
• In process of acquiring nutraceutical company Renaissance Health Publishing LLC, bolstering bottom line and product offerings

Medical Innovation Holdings, Inc. (OTC: MIHI), a Colorado-based publicly traded company, owns and operates strategically aligned healthcare service and product companies focused on the delivery of patient care, management services for physician offices, lab services, and pharma; and non-pharma medicines and alternatives to patients and consumers. Healthcare services are delivered and managed through the company’s MSO, 3Point Care. 3Point Care uses virtual telemedicine with a unique customized software and hardware platform as a way of bringing quality medical care to rural and medically underserved areas (MUAs) of the country.

3Point Care provides personalized high-tech, high-touch telemedicine encounters that link virtual health specialty doctors with traditional primary physicians and their patients. This approach helps reduce the cost of care while enhancing the quality of care. The company’s telemedicine approach is vastly different from other providers who rely on a monthly subscription to opt in the network and then require an encounter fee by the patient each and every time an on-demand physician is utilized. This approach breaks the continuum of care, relies on symptom-based diagnosis, does not except insurance, and there is no certainty you are dealing with a licensed practitioner. In summation they are not a medical practice but a contract service to deliver virtual care. Because 3Point Care deploys doctors through an actual medical practice, there is no subscription fee. The company works with anyone and everyone that has insurance including Medicare and Medicaid. It works hand and hand with the patient’s primary care physician so the continuum of care is always maintained. Part of the integrated software application enables the processing of insurance claims whereby doctors are paid for their services. This allows deductibles to be captured, allowing the patients to take advantage of medical tax deductions.

TeleLifeMd, a multi-disciplinary specialty healthcare practice with strong experience in telemedicine, is the primary deliverer of patient medical care. 3Point care has a unique and exclusive relationship with TeleLifeMD, acting as its management services organization by providing all levels of service that include scheduling, providing telemedicine hardware and software products and support, processing claims, paying all invoices and payroll incurred by TeleLifeMD, as well as any other service required to operate the practice.

BKare Diagnostics, another wholly owned subsidiary of MIHI, is tasked with delivering medical and health-related services such as laboratory testing, diagnostics, and alternative medicines primarily proven nutraceuticals. Its goal is to eventually infuse these products with 100% CBD/Hemp oil and THC-based oils to create new product categories as the law catches up with the cannabis marketplace. The opportunity to offer workable solutions that solve real health problems outside typical big pharma is very exciting for the company. It sees significant revenue opportunities in this space.

MIHI firmly believes the best way to provide access to high-quality medical care is through support and delivery of evidence-based virtual medicine, commonly known as telemedicine. With 80 million people living in rural, medically underserved areas of the nation, the company is poised to fill a glaring void in the healthcare industry by applying cutting-edge technology and time-tested business practices to deliver real-time care. Among the 16 areas of medical specialties available are cardiology, infertility, gastroenterology, pediatrics and obstetrics.

The company serves a number of constituents and stakeholders interested in reducing the cost of health care while simultaneously increasing the quality of care, improving access to health services for millions of people, and bringing value to company shareholders. Its unique platform incorporates every aspect of a telemedicine visit into a single, comprehensive package.

For more information, visit the company’s website at www.MedicalInnovationHoldings.com

Let us hear your thoughts: Medical Innovation Holdings, Inc. Message Board

• UnionPay module in Moxian+ User and Moxian+ Business apps gives access for potential joint venture partners to China’s largest payment processor
• Hao Qing Hu named as new company president and CEO in addition to Moxian director
• Seven directors elected to Moxian’s board at annual meeting, including Shewn International Group CEO Ms. Liu Shu Juan

Moxian, Inc. (NASDAQ: MOXC) has a key ingredient to attract joint venture partners in its growth strategy in China: the UnionPay module in its new User and Business apps. UnionPay is the largest payment processor in China and owns 25% of the global market for credit cards, third only to Visa and MasterCard (http://dtn.fm/dKz6h). It also has a presence in more than 160 countries worldwide, including the U.S.

Moxian is an integrated social media platform operator, striving to convert its unpaid Moxian+ Business and Moxian+ User platforms to paid within the online-to-offline (O2O) market in China. It connects users to merchant clients through games, rewards and social events. It offers Mo-Coin and Mo-Point reward systems.

MOXC’s special relationship to UnionPay gives businesses and vendors in China access to the largest payment processor in the country. MOXC has a new growth strategy employing partners to help it expand into more Chinese cities quicker and with lower costs. It signed an agreement in principal for its first joint venture partner, Shewn International Group of Shanghai, a successful marketer of fine wines in China. UnionPay makes MOXC a desirable partner for Shewn.

Crystal Equity Research LLC projects that Moxian will generate sales of $2.3 million in FY2018, in part from the new revenue stream of receiving a fee of 1% of all Shewn payments processed on Moxian’s UnionPay app (http://dtn.fm/76hJy). Crystal Equity Research also noted that Moxian has reduced its spending to $1.3 million for the quarter ended June 2017, down from the $5.4 million it spent in the prior quarter due to reduced selling, general and administrative (SG&A) expenses. Crystal Equity Research said it anticipates raising its projections for Moxian’s revenues after the Shewn joint venture is executed.

At the company’s annual meeting, Hao Qing Hu was named the company’s president and CEO and also elected as a director of the company. He has been a director of Moxian since January 2016 and, since September 2015, has been the general manager of subsidiary Moxian Beijing, maintaining responsibility for all operations.

Additionally, Ms. Liu Shu Juan was elected director. She is CEO of Shewn International Group and financial controller of Shanghai Shewn Co., Ltd., the company’s primary operator in China.

For more information, visit the company’s website at www.Moxian.com

• CBD market estimated to grow by 700% by 2020
• POTN has scientific focus on quality and therapeutic consistency
• POTN multiple product lines and global distribution
• Positioned for outsized share of the growth

It’s no wonder that medicinal marijuana, cannabis and hemp (cannabidiol) has become a veritable gold rush given the 700% market upsurge projected over the next three years (http://dtn.fm/Vx98o). Millions of people currently use cannabis, including CBD products, for medical therapies to treat pain, epilepsy, depression and multiple other maladies according to many abstracts and studies available from the U.S. National Library of Medicine National Institutes of Health. From these reports, there appears to be an abundance of scientific evidence proving the medical efficacy of cannabidiol (CBD) and investors are flooding the space seeking a share of this colossal 700% growth.

With such enormous upside in this space there are many pretenders to the throne and investors should be careful to look for companies that already have product lines, plus revenues and earnings instead of just hyped up pipe dreams. PotNetwork Holding Inc. (OTC: POTN) meets these criteria with an established product line and a successful business model. The company was recently mentioned in a NetworkNewsWire article, “Cannabis Companies Cater to an Increasingly Large and Diverse Industry” “(http://dtn.fm/3xK0l).

PotNetwork Holding is a holding company that owns subsidiaries that produce and distribute cannabidiol both in the U.S. and internationally. A primary operating entity of PotNetwork, Diamond CBD, Inc., produces and controls 15 different CBD brands that have gained international acceptance for both quality and consistency. With a staff of doctors, chemists and scientists, Diamond CBD is dedicated to developing and producing only the highest quality CBD oil across multiple products for a myriad of therapeutic and beneficial uses. Scientific research and depth of knowledge of natural hemp molecules and their particular properties determines the course of product development. All of the company’s products are made with federally legal cannabidiol (CBD) and are available in a variety of flavors and sizes for consumer appeal. The company insists on 100% natural lab-tested CBD ingredients with the process meticulously monitored from the source farm through every stage of production and final delivery to retail outlets.

Company efforts and attention to quality are paying off. PotNetwork recently announced that its Diamond CBD, Inc. subsidiary delivered a 30% month-over-month increase in revenues. Maria Gomez, Regional Vice President of Sales for Diamond CBD, Inc., stated in the news release, “We are consistently setting new sales records month after month and are excited to be able to report this type of continuing growth. We have taken our marketing efforts seriously. A commitment that is surely being revealed in the ongoing sales numbers.” These revenue results place PotNetwork on track to easily exceed 2017 projections.

With a scientific focus on quality and therapeutic consistency, 15 different brands in multiple flavors and sizes, with both domestic and international sales rapidly ramping up and in the midst of a 700% upsurge market, it looks like PotNetwork is well positioned to snag more than its fair share of this massive growth.

For more information, visit the company’s website at www.PotNetworkHolding.com

Let us hear your thoughts: PotNetwork Holding, Inc. Message Board

• Global alternative fuel and hybrid vehicle market is expected to grow to $614 billion by 2022, registering a compound annual growth rate (CAGR) of nearly 13 percent
• Greenkraft’s eco-friendly commercial trucks and alternative fuel systems offer environmentally friendly solutions with a price advantage and American performance
• California legislators are poised to increase funding for state’s purchase of alternative fuel-fed vehicles and trucks

Greenkraft, Inc. (OTCQB: GKIT), a nationally recognized company specializing in the production of alternative fuel automotive products, engines and commercial trucks, continues its revolutionary work on manufacturing cost-efficient commercial trucks powered by alternative fuels. Based in Santa Ana, California, Greenkraft’s expansion plans include construction of a larger manufacturing facility to accommodate this increasing demand for fuel-efficient trucks with varying carrying capacities.

Most vehicles, especially commercial trucks, are powered by either gasoline or diesel, but this trend is beginning to change. The U.S. government is funding several efforts to help consumers find the alternative fuel or fuel-efficient solutions that meet their needs. In California, legislators recently reached an agreement to direct up to $1.5 billion of revenue from the state’s greenhouse gas emissions allowance to expand its use of alternative transportation fuels, according to Natural Gas Intelligence, an industry publication (http://dtn.fm/PLX7n). In the legislative deal, nearly $900 million is earmarked for alternative fuel vehicles – including trucks and buses – purchased by the state.

California’s push to “move toward a future where trucks and buses produce either zero or virtually zero emissions” is at a pivotal point, according to an industry group in support of the increased funding. Several major U.S. cities are already using Greenkraft’s fuel-efficient trucks for their daily operations. These trucks not only produce fewer pollutants and less of an environmental impact; they also save these cities a healthy amount of money.

The world’s alternative fuel and hybrid vehicle market is expected to grow at a blistering pace over the next five years, reaching upward of $614 billion by 2022 and registering a nearly 13 percent compound annual growth rate, according to a report by Allied Market Research (http://dtn.fm/ei0Xl). Technological advances in alternative fuel vehicles and proactive government initiatives, such as the one under consideration in California, are helping to propel the market’s stunning growth.

Greenkraft CEO George Gemayel recently noted that the company’s ability to offer its truck line in sizes ranging from 14,500 lbs. to 33,000 lbs. makes sense for a variety of industries, including those needing refrigeration options. Greenkraft’s CNG trucks are becoming the standard alternative to diesel trucks in the United States.

“This increased demand and national recognition of our CNG truck line is set to dramatically increase GKIT’s revenue in the 2017 fiscal year,” Gemayel stated in a news release.

For more information, visit the company’s website at www.GreenkraftInc.com

Let us hear your thoughts: Greenkraft, Inc. Message Board

• Exploration of Bristol Lake Project reveals excellent lithium-bearing brine harvest potential
• Global lithium compounds market projected to reach U.S. $5.87 billion by 2020
• Technological advances provide access to low cost, battery-grade lithium materials
• World demand for lithium expected to increase 300% by 2025

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) is a Canadian-based energy exploration and development company that is building one of the largest portfolios of high quality, domestic U.S. lithium brine assets. Its data and technology driven project development model is grounded in knowledge, opportunity and speed. Standard Lithium is led by an innovative and results-oriented management team with a strong focus on technical skills. The company has acquired several prospective lithium brine projects with known geological values consistent with producing basins, including its primary focus, the Bristol Dry Lake, California brownfield project that is permitted for related mineral production with accompanying world class infrastructure which are expected to contribute to faster, lower cost exploration and commercial development programs.

Recent results from a geophysical survey of the 25,000-acre Bristol Lake site suggest a high concentration of lithium-bearing brines are present throughout the company’s mineral lease agreement claims. Standard Lithium’s strategic partner in the venture, National Chloride Corporation of America, is well established in the region. All necessary infrastructure is on site, which gives Standard Lithium immediate access to conduct exploration brine sampling, lithium extraction, evaporation and processing activities, all within a fast-track project development schedule.

World demand for lithium continues to surge. The global lithium compounds market is projected to reach U.S. $5.87 billion by 2020, at a compound annual growth rate of 13.22% between 2015 and 2020. Lithium-ion batteries are the fastest growing segment of the market.

Standard Lithium’s determination to provide battery-grade lithium materials is bolstered by its recently appointed Scientific Advisory Council. These leading lithium extraction scientists and process engineers will oversee and direct the necessary lithium extraction process testing work. In addition to the Bristol Lake Brine Project, the company signed a Memorandum of Understanding in August with an unnamed New York Stock Exchange-listed company on an option for Standard to acquire lithium exploration and productions rights on 30,000 net brine acres overlying the Smackover formation in a region with a history of commercial-scale brine processing. Management believes lithium-bearing brines are likely present in this area. Smackover brines are metal-rich brine anomalies in reservoir rocks along the Gulf Coast from east Texas to Florida known to be a prime lithium resource. This resource may be one of the most promising ones to develop, given that a large-scale brine extraction, processing and reinjection industry is already well established.

Recently, Standard Lithium closed a multi-million dollar private placement offering, which allows the company to advance its current projects and pursue strategic acquisitions in the lithium sector. The company is well positioned with significant exploration opportunities featuring low cost production costs, easy transport, proximity to demand, and access to innovative production methodology.

For more information, visit the company’s website at www.StandardLithium.com

• 92 Resources is an emerging junior exploration company
• Worldwide market for lithium is projected to grow 8.9% annually through 2019 to reach $1.7 billion
• Lithium-ion rechargeable batteries are used in the manufacture of electric vehicles, phones, laptops and digital cameras

92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) (FSE: R9G2) recently announced that it has acquired three new properties in Quebec, Canada, which are highly prospective in hard-rock lithium (http://dtn.fm/5xCgg). The sites are Corvette, Eastmain, and Lac du Beryl, and consist of 115 mineral claims on a combined 14,710 acres.

92 Resources is an emerging junior exploration company focused on acquiring and advancing strategic and prospective assets. It acquired 100% interest in the Hidden Lake Lithium Property and has achieved 97% lithium extraction from its pegmatites. Lithium is used for the manufacture of rechargeable lithium-ion batteries in phones, laptops, digital cameras and electric vehicles. Aluminum-lithium alloys are used in the manufacture of aircraft, bicycle frames and high speed trains. The global market for lithium is projected to grow 8.9% annually through 2019 to reach $1.7 billion, according to The Freedonia Group (http://dtn.fm/nPR96).

In a news release, Adrian Lamoureux, president and CEO of 92 Resources, said, “As we continue to aggressively advance our flagship Hidden Lake Lithium Project in NWT, we feel it is critical to maintain a pipeline of additional high-quality, early staged lithium pegmatite projects, each with potential as stand-alone properties. We are very excited by these new additions to the Company’s already high quality portfolio of assets”

In its corporate presentation (http://dtn.fm/pWKG0), 92 Resources explained that pegmatite is a type of crystal-heavy igneous rock and that hard rock lithium represents about one-third of all global reserves.

Brief due diligence site visits were made prior to the acquisition and pegmatite outcrop was confirmed at each property.

At the Corvette Project, 76 claims have been made. At the site visit, abundant coarse-grained spodumene crystals were identified. On the Eastman Project, 21 claims have been made, and it is highlighted by a large pegmatite outcrop. A total of 18 claims have been made at the Lac du Beryl Project, where several prominent outcrops of pegmatite have been seen.

For more information, visit the company’s website at www.92Resources.com

Let us hear your thoughts: 92 Resources Corp. Message Board

• Encouraging results noted for pancreatitis patients with exocrine pancreatic insufficiency
• Early data shows favorable safety profile, positive dose tolerance
• Favorable trends observed in other identified markers
• Study is being performed at four sites in Australia and New Zealand

New York-based AzurRx BioPharma Inc. (NASDAQ: AZRX), a biopharmaceutical company engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders, recently announced positive results from its ongoing clinical trials of MS1819-SD, a recombinant lipase, developed for the treatment of exocrine pancreatic insufficiency (EPI) caused by chronic pancreatitis.

In an update issued last week (http://dtn.fm/njK0J), AzurRx BioPharma said clinical trials of the first six patients being treated with MS1819-SD underway in Australia and New Zealand are showing encouraging results. Importantly, the company said patients showed a positive dose response curve and a 21% improvement in the coefficient of fat absorption in evaluable patients. The response rate went as high as 57% in one of the patients, and higher response rates were noted in patients with lower baseline CFA levels. Favorable trends were also observed in other endpoints with no serious adverse events reported.

“We are encouraged by these Phase IIa data,” Thijs Spoor, CEO of AzurRx BioPharma, stated in the news release. “They further confirm the activity of MS1819-SD and also demonstrate its dose response characteristics. Additionally, secondary efficacy endpoints are consistently aligning with the CFA data and the safety profile of MS1819-SD remains favorable.”

The primary objective of the phase IIa study is to investigate the safety of escalating doses of MS1819-SD in patients with chronic pancreatitis. The secondary objective is to investigate the efficacy of MS1819-SD in these patients by analysis of the coefficient of fat absorption and its change from baseline. Patient safety is of paramount importance and is assessed at the end of each treatment period, with attention being paid to immunoallergic effects, digestive symptoms and clinical laboratory results.

AzurRx Biopharma expects to enroll 12-15 patients in this open-label phase IIa trial of MS1819-SD, which is being conducted in partnership with Mayoly Spindler, a European pharmaceutical company. There are approximately 100,000 patients in the U.S. with EPI caused by chronic pancreatitis, according to the National Pancreas Foundation, with another estimated 30,000 patients with EPI caused by cystic fibrosis, the Cystic Fibrosis Foundation reports. When the pancreas can’t properly break down foods, poor digestion and malnutrition is the result. Patients with this condition are currently treated with porcine (derived from pig) pancreatic enzyme replacement pills.

The National Institutes of Health, analysts on Wall Street and the National Pancreas Foundation estimate the yearly market for pancreatic enzyme replacement therapy to be well over $800 million in the U.S. and at least $1.5 billion globally.

For more information, visit the company’s website at www.AzurRx.com

• Greenkraft is the only company to manufacture both CNG- and LPG-powered trucks
• Among few companies in the world to offer a refrigeration option for alternative fuel trucks
• Company has experienced a significant uptick in orders from fleet operators during 2017

Aiming to become the leading provider of alternative fuel trucks in North America, Greenkraft, Inc. (OTCQB: GKIT) is at the head of its class in introducing alternative fuel products that are both cost-effective and of the highest quality. The company was founded in 2008 with the objective of manufacturing alternative commercial forward cab trucks and alternative fuel systems for a variety of vehicles. Greenkraft’s commercial trucks operate under the power of alternative fuels CNG and LPG in classes 4, 5, 6 and 7.

The way is clear for Greenkraft to become number one in its field, as the company controls almost of all of the market share in the clean energy truck market. Greenkraft is currently the only manufacturer to offer trucks that are powered by both CNG and LPG, and electric vehicles are also forthcoming, according to the company’s website.

Greenkraft’s products include commercial trucks, alternative fuel systems and eco-friendly engines, all of which are environmentally friendly automotive solutions. The company’s products boast price advantages, American craftsmanship, enviro-friendliness and exceptional efficiency.

Greenkraft’s commercial trucks feature a cab forward design that enables the passenger area to be considerably larger than one finds in other similarly-sized vehicles. Several options are also offered regarding tank capacity, letting customers choose the most efficient model for their needs. Greenkraft is additionally one of the only companies on Earth that offers an alternative fuel truck with a refrigeration option.

Demand for Greenkraft’s trucks has greatly increased this year as orders have poured in from fleet operators throughout the United States. The various government incentives offered for companies that change over to alternative-fuel trucks have helped fuel this surge. Many of the fleet operators interested in Greenkraft’s pioneering trucks also operate their own filling stations, through which they are able to get CNG at low prices.

During 2017, Greenkraft has been executing a clear-cut growth plan, which has included the expansion of the company’s factory as well as the introduction of a new line of trucks—the G3 and G4—which will accommodate respective weights of 26,000 and 33,000 pounds.

For more information, visit the company’s website at www.GreenkraftInc.com

Let us hear your thoughts: Greenkraft, Inc. Message Board

• Wholly owned zinc project has estimate of 3.7 million tons of indicated resources and 4.09 million tons of inferred resources
• 525 acres of mineral rights includes zinc with significant assets of copper, silver and gold
• Advanced-stage project led by experienced management team with key technical advisors
• Global shortfall in zinc production equals significant opportunity

Blue Moon Zinc Corp. (TSX.V: MOON) (OTC: BMOOF), a mineral exploration company, is focused on developing its advanced-stage, wholly owned Blue Moon zinc project in central California. The project sits within Mariposa County, an area of active mines and exploration projects since it was part of the California gold rush era. Blue Moon’s 525 acres of mineral rights are assigned to patented and unpatented claims accessible by a gravel road off a nearby highway with main utility lines nearby.

The Blue Moon deposit is one of many located in the Foothills Massive Sulphide Belt in the Sierra Nevada Mountains of California. The property has a long history of exploration and saw small-scale mining during World War II. The current project, to be mined by underground methods, contains an estimated 3.70 million tons with a grade of 8.33% zinc equivalent for approximately 377 million pounds of zinc in the indicated category and another 4.09 million tons with a grade of 7.84% zinc equivalence for approximately 395 pounds of zinc in the inferred category. Significant bi-products of copper, silver and gold are also indicated. The deposit is open at depth and along strike with a high likelihood of expansion.

Current spot prices for zinc is approximately $1.40 per pound, which increases the potential returns of the Blue Moon project.

The historical database shows extensive plans to put the Blue Moon project into production, including several scoping and optimization studies. Past environmental work performed, along with an historical permit and reclamation plan approved for certain underground development, highlights past local county support for the project. These historical studies and permits are expected to help fast track the project’s progress as they form an excellent base for the upcoming Preliminary Economic Assessment and later feasibility study.

Among the significant historical studies conducted is a 1998 metallurgical report that shows recovery rates of 95 percent for zinc and lead, 93 percent for copper, 65 percent for silver and 70 percent for gold (http://dtn.fm/F3AhW). The report indicates that simple processing methods will produce premium concentrates with easy separation of the economic minerals.

Blue Moon CEO Patrick McGrath, who has 20 years of experience in financing and executive roles in the junior mining public sector, is joined by a management team with successful track records in leading and participating in significant mineral discoveries with development-stage mining companies. The Blue Moon team also includes a member who permitted and built the Soledad mine in southern California in 2016 and a member who re-started the Mesquite mine in southern California. Local knowledge and know-how is key. The company also plans to engage a recognized third-party engineering firm to prepare a preliminary economic assessment report, expected for release in the first quarter of 2018, to demonstrate the economic viability of the Blue Moon mineral resources.

For more information, visit the company’s website at www.BlueMoonMining.com

Let us hear your thoughts: Blue Moon Zinc Corp. Message Board